INTERLEUKIN 2 RECEPTORS IN AGING
INTERLEUKIN 2 RECEPTORS IN AGING
批准号:
3118186
负责人:
FRANK M ORSON
金额:
$7.01万
依托单位国家:
美国
项目类别:
财政年份:
1987
资助国家:
美国
项目状态:
已结题
起止时间:
1987-09-01 至 1990-08-31
关键词:
T lymphocyte affinity chromatography aging cell growth regulation cell sorting enzyme linked immunosorbent assay gel electrophoresis immunogenetics interleukin 2 laboratory mouse leukocyte activation /transformation lysozyme membrane structure mitogens proteolysis thymus neoplasms tissue /cell culture
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The immune system is an especially attractive organ system in
which to study the diminished proliferative capacity of cells in
the elderly due to accessibility of cells and the clinical
significance of immune function defects. The aged have a
diminished production of interleukin 2 (IL-2), an essential growth
factor for T cell proliferation. In the mouse, exogenous IL-2 was
shown to largely correct many in vitro functional deficits. With
human cells in vitro, however, this has not been effective; thus;
other factors must also play important roles. To induce cell
growth, IL-2 must interact with specific high affinity receptors
(IL-2R) displayed on the surface of activated T cells. Such
activated T cells also express low affinity IL-2 receptors and
release a soluble from of IL-2R, neither of whose functions are
known. Preliminary experiments demonstrate that the aged
release a relative excess of soluble IL-2R for the level of
mitogen-induced proliferation. The expression of membrane-
bound IL-2R has not been well-characterized in the elderly, but
in a limited number of donors, the aged appear to express a
higher density of receptors per activated cell.
This proposal is designed to investigate both membrane-bound
and soluble IL-2R in healthy aging donors. membrane-bound IL-
2R will be studied utilizing 125I-labelled IL-2 to determine the
number, affinity, and kinetics of expression of both high and low
affinity receptor populations. Soluble IL-2R will be investigated
by quantitating its release from stimulated T-cells. The origins
of soluble IL-2R will also be examined in the old and young by
intrinsic radiolabelling experiments and the use of proteolytic
and lysosomal enzyme inhibitors. The functions of soluble IL-2R
will be analyzed utilizing preparations of a recombinant DNA-
produced IL-2R which has been modified to lack the
transmembrane portion of the molecule, as well as preparations
of soluble IL-2R crudely purified from culture supernatants. In
vitro thymic hormones will be tested for effects on IL-2R
expression in cells from the aged.
Experimental methods for these projects include: a) cell
separations using standard techniques, b) cell culture with a
variety of lymphocyte activators, c) assay of membrane-bound
IL-2R binding by radiolabelled IL-2, d) determination of soluble
IL-2R by enzyme-linked immunosorbent assay, e) polyacrylamide
gel electrophoresis, and f) gel permeation chromatography.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development of Novel Vaccines for Cocaine Abuse
-
批准号:8316422
-
项目类别:
-
资助金额:$28.64万
-
财政年份:2010
-
负责人:FRANK M ORSON
-
依托单位:
Development of Novel Vaccines for Cocaine Abuse
-
批准号:8535713
-
项目类别:
-
资助金额:$27.71万
-
财政年份:2010
-
负责人:FRANK M ORSON
-
依托单位:
Development of Novel Vaccines for Cocaine Abuse
-
批准号:8707412
-
项目类别:
-
资助金额:$28.76万
-
财政年份:2010
-
负责人:FRANK M ORSON
-
依托单位:
Development of Novel Vaccines for Cocaine Abuse
-
批准号:8147727
-
项目类别:
-
资助金额:$37.95万
-
财政年份:2010
-
负责人:FRANK M ORSON
-
依托单位:
Developing Immunotherapeutics for Methamphetamine Abuse
-
批准号:7894904
-
项目类别:
-
资助金额:$69.0万
-
财政年份:2009
-
负责人:FRANK M ORSON
-
依托单位:
Vaccines for Sustainable Therapy of Opiate Addiction
-
批准号:7695925
-
项目类别:
-
资助金额:$39.05万
-
财政年份:2009
-
负责人:FRANK M ORSON
-
依托单位:
Vaccines for Sustainable Therapy of Opiate Addiction
-
批准号:7892450
-
项目类别:
-
资助金额:$36.01万
-
财政年份:2009
-
负责人:FRANK M ORSON
-
依托单位:
Vaccines for Sustainable Therapy of Opiate Addiction
-
批准号:8277437
-
项目类别:
-
资助金额:$34.93万
-
财政年份:2009
-
负责人:FRANK M ORSON
-
依托单位:
Vaccines for Sustainable Therapy of Opiate Addiction
-
批准号:8076921
-
项目类别:
-
资助金额:$34.93万
-
财政年份:2009
-
负责人:FRANK M ORSON
-
依托单位:
Oral Delivery of DNA Vaccines
-
批准号:6557378
-
项目类别:
-
资助金额:$7.53万
-
财政年份:2002
-
负责人:FRANK M ORSON
-
依托单位:
Oral Delivery of DNA Vaccines
-
批准号:6659776
-
项目类别:
-
资助金额:$7.53万
-
财政年份:2002
-
负责人:FRANK M ORSON
-
依托单位:
INTERLEUKIN 2 RECEPTORS IN AGING
-
批准号:3118187
-
项目类别:
-
资助金额:$5.78万
-
财政年份:1987
-
负责人:FRANK M ORSON
-
依托单位:
INTERLEUKIN 2 RECEPTORS IN AGING
-
批准号:3118185
-
项目类别:
-
资助金额:$7.35万
-
财政年份:1987
-
负责人:FRANK M ORSON
-
依托单位:
海外基金